Literature DB >> 28424160

Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice.

Chao-Sheng Lo1, Yixuan Shi1, Isabelle Chenier1, Anindya Ghosh1, Chin-Han Wu1, Jean-Francois Cailhier1, Jean Ethier1, Jean-Baptiste Lattouf1, Janos G Filep2, Julie R Ingelfinger3, Shao-Ling Zhang4, John S D Chan4.   

Abstract

We investigated the mechanism of heterogeneous nuclear ribonucleoprotein F (hnRNP F) renoprotective action in a type 2 diabetes (T2D) mouse model (db/db). Immortalized rat renal proximal tubular cells (IRPTCs) and kidneys from humans with T2D were also studied. The db/db mice developed hyperglycemia, oxidative stress, and nephropathy at age 20 weeks compared with their db/m littermates. These abnormalities, with the exception of hyperglycemia, were attenuated in db/dbhnRNP F-transgenic (Tg) mice specifically overexpressing hnRNP F in their RPTCs. Sirtuin-1, Foxo3α, and catalase expression were significantly decreased in RPTCs from db/db mice and normalized in db/dbhnRNP F-Tg mice. In vitro, hnRNP F overexpression stimulated Sirtuin-1 and Foxo3α with downregulation of acetylated p53 expression and prevented downregulation of Sirtuin-1 and Foxo3α expression in IRPTCs by high glucose plus palmitate. Transfection of Sirtuin-1 small interfering RNA prevented hnRNP F stimulation of Foxo3α and downregulation of acetylated p53 expression. hnRNP F stimulated Sirtuin-1 transcription via hnRNP F-responsive element in the Sirtuin-1 promoter. Human T2D kidneys exhibited more RPTC apoptosis and lower expression of hnRNP F, SIRTUIN-1, and FOXO3α than nondiabetic kidneys. Our results demonstrate that hnRNP F protects kidneys against oxidative stress and nephropathy via stimulation of Sirtuin-1 expression and signaling in diabetes.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28424160      PMCID: PMC5482081          DOI: 10.2337/db16-1588

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

1.  Heterogeneous nuclear ribonucleoprotein K modulates angiotensinogen gene expression in kidney cells.

Authors:  Chih-Chang Wei; Shao-Ling Zhang; Yun-Wen Chen; Deng-Fu Guo; Julie R Ingelfinger; Karol Bomsztyk; John S D Chan
Journal:  J Biol Chem       Date:  2006-07-12       Impact factor: 5.157

2.  Androgen-dependent regulation of human angiotensinogen expression in KAP-hAGT transgenic mice.

Authors:  Y Ding; C D Sigmund
Journal:  Am J Physiol Renal Physiol       Date:  2001-01

3.  Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice.

Authors:  Nicolas Godin; Fang Liu; Garnet J Lau; Marie-Luise Brezniceanu; Isabelle Chénier; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Kidney Int       Date:  2010-03-17       Impact factor: 10.612

Review 4.  Molecular basis of renal fibrosis.

Authors:  A A Eddy
Journal:  Pediatr Nephrol       Date:  2000-12       Impact factor: 3.714

5.  Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats.

Authors:  H Elbe; N Vardi; M Esrefoglu; B Ates; S Yologlu; C Taskapan
Journal:  Hum Exp Toxicol       Date:  2014-05-08       Impact factor: 2.903

6.  Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice.

Authors:  Yixuan Shi; Chao-Sheng Lo; Isabelle Chenier; Hasna Maachi; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Am J Physiol Renal Physiol       Date:  2013-04-03

7.  Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice.

Authors:  Chao-Sheng Lo; Shiao-Ying Chang; Isabelle Chenier; Janos G Filep; Julie R Ingelfinger; Shao Ling Zhang; John S D Chan
Journal:  Diabetes       Date:  2012-06-04       Impact factor: 9.461

8.  Bcl-2-modifying factor induces renal proximal tubular cell apoptosis in diabetic mice.

Authors:  Garnet J Lau; Nicolas Godin; Hasna Maachi; Chao-Sheng Lo; Shyh-Jong Wu; Jian-Xin Zhu; Marie-Luise Brezniceanu; Isabelle Chénier; Joelle Fragasso-Marquis; Jean-Baptiste Lattouf; Jean Ethier; Janos G Filep; Julie R Ingelfinger; Viji Nair; Matthias Kretzler; Clemens D Cohen; Shao-Ling Zhang; John S D Chan
Journal:  Diabetes       Date:  2011-12-30       Impact factor: 9.461

9.  Overexpression of heterogeneous nuclear ribonucleoprotein F stimulates renal Ace-2 gene expression and prevents TGF-β1-induced kidney injury in a mouse model of diabetes.

Authors:  Chao-Sheng Lo; Yixuan Shi; Shiao-Ying Chang; Shaaban Abdo; Isabelle Chenier; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Diabetologia       Date:  2015-08-01       Impact factor: 10.122

10.  Sirt1 deletion leads to enhanced inflammation and aggravates endotoxin-induced acute kidney injury.

Authors:  Rong Gao; Jiao Chen; Yuxin Hu; Zhenyu Li; Shuxia Wang; Sreerama Shetty; Jian Fu
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

View more
  12 in total

Review 1.  SIRT1-SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms.

Authors:  Wenxiu Qi; Cheng Hu; Daqing Zhao; Xiangyan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-13       Impact factor: 6.055

2.  Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.

Authors:  Shuiling Zhao; Anindya Ghosh; Chao-Sheng Lo; Isabelle Chenier; James W Scholey; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

3.  FOXO1 Overexpression Attenuates Tubulointerstitial Fibrosis and Apoptosis in Diabetic Kidneys by Ameliorating Oxidative Injury via TXNIP-TRX.

Authors:  Linlin Ji; Qingzhu Wang; Fengjuan Huang; Tingting An; Feng Guo; Yanyan Zhao; Yang Liu; Yanyan He; Yi Song; Guijun Qin
Journal:  Oxid Med Cell Longev       Date:  2019-03-06       Impact factor: 6.543

4.  Heterogeneous Nuclear Ribonucleoprotein F Mediates Insulin Inhibition of Bcl2-Modifying Factor Expression and Tubulopathy in Diabetic Kidney.

Authors:  Anindya Ghosh; Shuiling Zhao; Chao-Sheng Lo; Hasna Maachi; Isabelle Chenier; Muhammad Abdul Lateef; Shaaban Abdo; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Sci Rep       Date:  2019-04-30       Impact factor: 4.379

5.  Regulation of left atrial fibrosis induced by mitral regurgitation by SIRT1.

Authors:  Dong Zhang; Bo Li; Bin Li; Yue Tang
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

6.  Metformin Reduces the Senescence of Renal Tubular Epithelial Cells in Diabetic Nephropathy via the MBNL1/miR-130a-3p/STAT3 Pathway.

Authors:  Xue Jiang; Xue-Lei Ruan; Yi-Xue Xue; Shuang Yang; Mai Shi; Li-Ning Wang
Journal:  Oxid Med Cell Longev       Date:  2020-02-10       Impact factor: 6.543

7.  Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes.

Authors:  Kana N Miyata; Chao-Sheng Lo; Shuiling Zhao; Xin-Ping Zhao; Isabelle Chenier; Michifumi Yamashita; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Diabetologia       Date:  2021-08-09       Impact factor: 10.122

Review 8.  SIRT1 Is a Potential Drug Target for Treatment of Diabetic Kidney Disease.

Authors:  Yifei Zhong; Kyung Lee; John Cijiang He
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-17       Impact factor: 5.555

9.  The Antidiabetic and Antinephritic Activities of Tuber melanosporum via Modulation of Nrf2-Mediated Oxidative Stress in the db/db Mouse.

Authors:  Xue Jiang; Shanshan Teng; Xue Wang; Shan Li; Yaqin Zhang; Di Wang
Journal:  Oxid Med Cell Longev       Date:  2018-07-29       Impact factor: 6.543

Review 10.  Role of sirtuin-1 in diabetic nephropathy.

Authors:  Wanning Wang; Weixia Sun; Yanli Cheng; Zhonggao Xu; Lu Cai
Journal:  J Mol Med (Berl)       Date:  2019-02-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.